Ok Biotech Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.049x

Ok Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Ok Biotech Co Ltd (4155) has a cash flow conversion efficiency ratio of 0.049x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$126.93 Million ≈ $4.00 Million USD) by net assets (NT$2.57 Billion ≈ $81.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Ok Biotech Co Ltd (2009–2025)

Cash flow conversion efficiency of Ok Biotech Co Ltd from 2009 to 2025. This chart illustrates how Ok Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Ok Biotech Co Ltd for real-time trading data and today's change.

Ok Biotech Co Ltd Cash Flow Conversion Ratio Explained

Ok Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Ok Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ok Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see Ok Biotech Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Haulotte Group SA PA:PIG	0.029x
Nickel 28 Capital Corp V:NKL	0.002x
Blink Charging Co NASDAQ:BLNK	0.011x
Bound and Beyond PCL BK:BEYOND	0.026x
TAFI Industries Bhd KLSE:7211	0.035x
Marmota Ltd AU:MEU	-0.010x
EKOS IS:EKOS	0.009x
NeueHealth Inc NYSE:NEUE	0.007x

Annual Cash Flow Conversion Efficiency for Ok Biotech Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Ok Biotech Co Ltd from 2009 to 2025. Review Ok Biotech Co Ltd (4155) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$2.58 Billion ≈ $81.16 Million	NT$319.57 Million ≈ $10.07 Million	0.124x	+383.18%
2024-12-31	NT$2.57 Billion ≈ $80.87 Million	NT$65.90 Million ≈ $2.08 Million	0.026x	+1996.54%
2023-12-31	NT$2.40 Billion ≈ $75.46 Million	NT$2.93 Million ≈ $92.41K	0.001x	-99.06%
2022-12-31	NT$1.85 Billion ≈ $58.17 Million	NT$240.53 Million ≈ $7.58 Million	0.130x	+913.18%
2021-12-31	NT$1.70 Billion ≈ $53.65 Million	NT$21.90 Million ≈ $689.84K	0.013x	-84.86%
2020-12-31	NT$1.74 Billion ≈ $54.79 Million	NT$147.70 Million ≈ $4.65 Million	0.085x	+144.78%
2019-12-31	NT$1.30 Billion ≈ $41.02 Million	NT$45.18 Million ≈ $1.42 Million	0.035x	-65.83%
2018-12-31	NT$1.27 Billion ≈ $39.95 Million	NT$128.75 Million ≈ $4.06 Million	0.102x	+19.16%
2017-12-31	NT$1.21 Billion ≈ $38.00 Million	NT$102.77 Million ≈ $3.24 Million	0.085x	-69.12%
2016-12-31	NT$944.80 Million ≈ $29.77 Million	NT$260.72 Million ≈ $8.21 Million	0.276x	-9.41%
2015-12-31	NT$950.15 Million ≈ $29.94 Million	NT$289.44 Million ≈ $9.12 Million	0.305x	+864.81%
2014-12-31	NT$849.48 Million ≈ $26.76 Million	NT$-33.83 Million ≈ $-1.07 Million	-0.040x	-127.88%
2013-12-31	NT$609.65 Million ≈ $19.21 Million	NT$87.08 Million ≈ $2.74 Million	0.143x	-18.43%
2012-12-31	NT$452.10 Million ≈ $14.24 Million	NT$79.17 Million ≈ $2.49 Million	0.175x	-42.99%
2011-12-31	NT$303.11 Million ≈ $9.55 Million	NT$93.12 Million ≈ $2.93 Million	0.307x	+463.30%
2010-12-31	NT$230.78 Million ≈ $7.27 Million	NT$-19.52 Million ≈ $-614.83K	-0.085x	-247.52%
2009-12-31	NT$121.25 Million ≈ $3.82 Million	NT$6.95 Million ≈ $218.96K	0.057x	--

About Ok Biotech Co Ltd

TW:4155 Taiwan Medical Devices

Market Cap

$60.97 Million

NT$1.94 Billion TWD

Market Cap Rank

#20919 Global

#1267 in Taiwan

Share Price

NT$16.65

Change (1 day)

-3.76%

52-Week Range

NT$12.90 - NT$17.30

All Time High

NT$37.98